158 related articles for article (PubMed ID: 7768776)
21. In-vitro activity of the fluoroquinolone trovafloxacin against penicillin-susceptible and -resistant Streptococcus pneumoniae.
Klugman K; Wasas A
J Antimicrob Chemother; 1995 Nov; 36(5):873-4. PubMed ID: 8626270
[No Abstract] [Full Text] [Related]
22. Resistance of Streptococcus pneumoniae to fluoroquinolones--United States, 1995-1999.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2001 Sep; 50(37):800-4. PubMed ID: 11785571
[TBL] [Abstract][Full Text] [Related]
23. Comparative in vitro activity of older and newer fluoroquinolones against respiratory tract pathogens.
Esposito S; Noviello S; Ianniello F
Chemotherapy; 2000; 46(5):309-14. PubMed ID: 10965095
[TBL] [Abstract][Full Text] [Related]
24. Activity of gemifloxacin against penicillin- and ciprofloxacin-resistant Streptococcus pneumoniae displaying topoisomerase- and efflux-mediated resistance mechanisms.
Heaton VJ; Goldsmith CE; Ambler JE; Fisher LM
Antimicrob Agents Chemother; 1999 Dec; 43(12):2998-3000. PubMed ID: 10582896
[TBL] [Abstract][Full Text] [Related]
25. Comparative activity of the new fluoroquinolone Bay y3118 against 177 penicillin susceptible and resistant pneumococci.
Spangler SK; Jacobs MR; Appelbaum PC
Eur J Clin Microbiol Infect Dis; 1993 Dec; 12(12):965-7. PubMed ID: 8187796
[TBL] [Abstract][Full Text] [Related]
26. Antipneumococcal activity of DW-224a, a new quinolone, compared to those of eight other agents.
Kosowska-Shick K; Credito K; Pankuch GA; Lin G; Bozdogan B; McGhee P; Dewasse B; Choi DR; Ryu JM; Appelbaum PC
Antimicrob Agents Chemother; 2006 Jun; 50(6):2064-71. PubMed ID: 16723567
[TBL] [Abstract][Full Text] [Related]
27. In-vitro and in-vivo activity of trovafloxacin against Streptococcus pneumoniae.
Klugman KP; Gootz TD
J Antimicrob Chemother; 1997 Jun; 39 Suppl B():51-5. PubMed ID: 9222070
[TBL] [Abstract][Full Text] [Related]
28. [Flouroquinolone activity in clinical isolates of Streptococcus pneumoniae with different susceptibility to penicilline: an epidemiological study in five cities of Mexico].
Calva-Mercado JJ; Castillo G; López-Vidal Y
Gac Med Mex; 2005; 141(4):253-8. PubMed ID: 16164118
[TBL] [Abstract][Full Text] [Related]
29. In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin, pefloxacin, sparfloxacin and trovafloxacin against gram-positive and gram-negative pathogens from respiratory tract infections.
Hoogkamp-Korstanje JA
J Antimicrob Chemother; 1997 Sep; 40(3):427-31. PubMed ID: 9338498
[TBL] [Abstract][Full Text] [Related]
30. Pneumococcal resistance in the UK.
Goldsmith CE; Moore JE; Murphy PG
J Antimicrob Chemother; 1997 Dec; 40 Suppl A():11-8. PubMed ID: 9484868
[TBL] [Abstract][Full Text] [Related]
31. Comparative in vitro activities of four new fluoroquinolones against Streptococcus pneumoniae determined by Etest.
Waites K; Brookings E; Nix S; Robinson A; Gray B; Swiatlo E
Int J Antimicrob Agents; 1998 Feb; 9(4):215-8. PubMed ID: 9573490
[TBL] [Abstract][Full Text] [Related]
32. [The frequency of Streptococcus pneumoniae strains and sensitivity surveillance for several antibiotics in Gifu Prefecture].
Ishigo S; Tamaya T; Matsubara S; Suematsu H; Sawamura H; Matsukawa Y; Hashido H; Iwata I; Mikamo H
Jpn J Antibiot; 2000 Dec; 53(12):652-9. PubMed ID: 11234221
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of trovafloxacin against penicillin-susceptible and multiresistant strains of Streptococcus pneumoniae in a mouse pneumonia model.
Bédos JP; Rieux V; Bauchet J; Muffat-Joly M; Carbon C; Azoulay-Dupuis E
Antimicrob Agents Chemother; 1998 Apr; 42(4):862-7. PubMed ID: 9559797
[TBL] [Abstract][Full Text] [Related]
34. Longitudinally tracking fluoroquinolone resistance and its determinants in penicillin-susceptible and -nonsusceptible Streptococcus pneumoniae isolates in Hong Kong, 2000 to 2005.
Ip M; Chau SS; Chi F; Cheuk ES; Ma H; Lai RW; Chan PK
Antimicrob Agents Chemother; 2007 Jun; 51(6):2192-4. PubMed ID: 17371818
[TBL] [Abstract][Full Text] [Related]
35. Susceptibility of penicillin-susceptible and -resistant pneumococci to CFC-222, a new fluoroquinolone.
Kim JH; Kang JA; Lee Y; Lee KH; Lee JH; Choi EC; Kim BK
J Antimicrob Chemother; 1998 Oct; 42(4):527-30. PubMed ID: 9818754
[TBL] [Abstract][Full Text] [Related]
36. Grepafloxacin against penicillin-resistant pneumococci in the rabbit meningitis model.
Gerber CM; Tovar L; Cottagnoud M; Neftel KA; Täuber MG; Cottagnoud P
J Antimicrob Chemother; 2000 Aug; 46(2):249-53. PubMed ID: 10933648
[TBL] [Abstract][Full Text] [Related]
37. In vitro activity of newer quinolones on Streptococcus pneumoniae isolated from outpatients.
Lontie M; Liekens K; Deschilder I
Acta Clin Belg; 1998 Aug; 53(4):285-6. PubMed ID: 9795451
[No Abstract] [Full Text] [Related]
38. Activity of trovafloxacin against blood isolates of Streptococcus pneumoniae in Sweden.
Liljequist BO; Hoffman BM; Hedlund J
Eur J Clin Microbiol Infect Dis; 1996 Aug; 15(8):671-5. PubMed ID: 8894578
[TBL] [Abstract][Full Text] [Related]
39. Comparative in-vitro efficacy of fluoroquinolones against Streptococcus pneumoniae recovered from bacterial keratitis as determined by E-test.
Ramakrishnan R; Ramesh S; Bharathi MJ; Amuthan M; Viswanathan S
Indian J Pathol Microbiol; 2010; 53(2):276-80. PubMed ID: 20551532
[TBL] [Abstract][Full Text] [Related]
40. Antipneumococcal activity of ulifloxacin compared to levofloxacin and ciprofloxacin.
Pallecchi L; Riccobono E; Montagnani F; Di Maggio T; Mantengoli E; Pollini S; Rossolini GM
J Chemother; 2011 Oct; 23(5):308-9. PubMed ID: 22005066
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
